Actemra and Demyelinating disorders
Result of checking the interaction of drug Actemra and disease Demyelinating disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Clinical studies have reported that tocilizumab may have an effect on demyelinating disorders such as multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Monitor patients for signs and symptoms potentially indicative of demyelinating disorders. Caution should be exercise when considering the use of tocilizumab in patients with preexisting or recent onset demyelinating disorders.
Generic Name: tocilizumab
Brand Name: Actemra, Actemra ACTPen
Synonyms: n.a.
Actemra - zaburzenia demielinizacyjne 
Actemra - distúrbios desmielinizantes 
Actemra - gangguan demyelining 
Actemra - gangguan demielinasi 
Actemra - disturbi demielinizzanti 
Actemra - troubles démyélinisants 
Actemra - demyelinisierende Störungen 
Actemra - trastornos desmielinizantes 
Actemra - демиелинизирующие расстройства 
Actemra - demiyelinizan bozukluklar 
Actemra - اضطرابات إزالة الميالين 
Actemra - 脱髓鞘疾病